Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Simoons

Showing results (321-330 of 338) with videos related to

Pageof 34
Sort By:
American Heart Journal|June 30, 2001
Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experienceC F Lundergan, A M Ross, W F McCarthy, et al.
European Heart Journal|July 13, 2004
Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years)J W Roos-Hesselink, F J Meijboom, S E C Spitaels, et al.
Circulation|May 21, 1998
Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries TrialA M Ross, K S Coyne, E Moreyra, et al.
JAMA|January 27, 2000
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin TherapyJ H Alexander, R A Sparapani, K W Mahaffey, et al.
Circulation|October 7, 1998
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhageM A Sloan, C A Sila, K W Mahaffey, et al.
The American Journal of Cardiology|June 26, 2001
Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trialS M Al-Khatib, K S Pieper, K L Lee, et al.
Circulation|February 23, 2000
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT InvestigatorsN S Kleiman, A M Lincoff, G C Flaker, et al.
Circulation|January 26, 1999
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries StudyC Y Tung, C B Granger, M A Sloan, et al.
Circulation|September 7, 2000
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial InvestigatorsM T Roe, R A Harrington, D M Prosper, et al.
Circulation|June 7, 2000
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT InvestigatorsE Boersma, K S Pieper, E W Steyerberg, et al.
Pageof 34

Showing results (321-330 of 338) with videos related to

Sort By:
Pageof 34
American Heart Journal|June 30, 2001
Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experienceC F Lundergan, A M Ross, W F McCarthy, et al.
European Heart Journal|July 13, 2004
Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years)J W Roos-Hesselink, F J Meijboom, S E C Spitaels, et al.
Circulation|May 21, 1998
Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries TrialA M Ross, K S Coyne, E Moreyra, et al.
JAMA|January 27, 2000
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin TherapyJ H Alexander, R A Sparapani, K W Mahaffey, et al.
Circulation|October 7, 1998
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhageM A Sloan, C A Sila, K W Mahaffey, et al.
The American Journal of Cardiology|June 26, 2001
Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trialS M Al-Khatib, K S Pieper, K L Lee, et al.
Circulation|February 23, 2000
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT InvestigatorsN S Kleiman, A M Lincoff, G C Flaker, et al.
Circulation|January 26, 1999
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries StudyC Y Tung, C B Granger, M A Sloan, et al.
Circulation|September 7, 2000
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial InvestigatorsM T Roe, R A Harrington, D M Prosper, et al.
Circulation|June 7, 2000
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT InvestigatorsE Boersma, K S Pieper, E W Steyerberg, et al.
Pageof 34